Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.22.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Common Stock
Additional Paid-in Capital
AOCI Attributable to Parent
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ (48,736) $ 52,809 $ 35,228 $ 65,222 $ 2 $ 10,131 $ (982) $ (211,146)
Beginning balance, shares at Dec. 31, 2020 [1]   21,615,723 8,306,818 12,804,176 17,664,015      
Exercise of stock options 673         673    
Exercise of stock options, shares [1]         570,585      
Stock compensation expense 4,501         4,501    
Issuance of shares to FP Credit Partners. L.P. 8,065         8,065    
Issuance of shares to FP Credit Partners. L.P., shares [1]         977,724      
Exercise of series C preferred warrants, shares [1]       146,919        
Exercise of series C preferred warrants 891     $ 891        
Net loss (46,560)             (46,560)
Foreign currency translation adjustments 467           467  
Net unrealized loss on investments (net of tax) 0              
Ending balance at Jun. 30, 2021 (80,699) $ 52,809 $ 35,228 $ 66,113 $ 2 23,370 (515) (257,706)
Ending balance, shares at Jun. 30, 2021 [1]   21,615,723 8,306,818 12,951,095 19,212,324      
Beginning balance at Mar. 31, 2021 (65,600) $ 52,809 $ 35,228 $ 65,222 $ 2 12,933 (950) (230,844)
Beginning balance, shares at Mar. 31, 2021 [1]   21,615,723 8,306,818 12,804,176 17,915,515      
Exercise of stock options 378         378    
Exercise of stock options, shares [1]         319,085      
Stock compensation expense 1,994         1,994    
Issuance of shares to FP Credit Partners. L.P. 8,065         8,065    
Issuance of shares to FP Credit Partners. L.P., shares [1]         977,724      
Exercise of series C preferred warrants, shares [1]       146,919        
Exercise of series C preferred warrants 891     $ 891        
Net loss (26,862)             (26,862)
Foreign currency translation adjustments 435           435  
Net unrealized loss on investments (net of tax) 0              
Ending balance at Jun. 30, 2021 (80,699) $ 52,809 $ 35,228 $ 66,113 $ 2 23,370 (515) (257,706)
Ending balance, shares at Jun. 30, 2021 [1]   21,615,723 8,306,818 12,951,095 19,212,324      
Beginning balance at Dec. 31, 2021 188,864       $ 15 418,575 732 (230,458)
Beginning balance, shares at Dec. 31, 2021         151,154,614      
Exercise of stock options $ 796         796    
Exercise of stock options, shares 494,664       494,664      
Vesting of restricted stock units, shares net of tax withholdings         25,345      
Vesting of restricted stock units, value net of tax withholdings $ (17)         (17)    
Stock compensation expense 5,198         5,198    
Net loss (58,613)             (58,613)
Foreign currency translation adjustments (353)           (353)  
Net unrealized loss on investments (net of tax) (83)              
Ending balance at Jun. 30, 2022 136,124       $ 15 424,884 296 (289,071)
Ending balance, shares at Jun. 30, 2022         151,929,995      
Beginning balance at Mar. 31, 2022 175,492       $ 15 421,502 2,591 (248,616)
Beginning balance, shares at Mar. 31, 2022         151,650,692      
Exercise of stock options 158         158    
Exercise of stock options, shares         2,600      
Vesting of restricted stock units, shares net of tax withholdings         21,331      
Vesting of restricted stock units, value net of tax withholdings (17)         (17)    
Issuance of common stock upon ESPP purchase 332         332    
Issuance of common stock upon ESPP purchase, shares         255,372      
Stock compensation expense 2,909         2,909    
Net loss (40,455)             (40,455)
Foreign currency translation adjustments (2,212)           (2,212)  
Net unrealized loss on investments (net of tax) (83)           (83)  
Ending balance at Jun. 30, 2022 $ 136,124       $ 15 $ 424,884 $ 296 $ (289,071)
Ending balance, shares at Jun. 30, 2022         151,929,995      
[1] The shares of the Company’s common and convertible preferred stock, prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.7058 established in the Merger.